Early Access Program
Where innovation meets opportunity for patients in France.
Implementing an Early Access Program (EAP) in France requires a local "Exploitant" for regulatory compliance, involving significant resource allocation, establishing a reliable supply chain, and ensuring effective local stakeholder communication, all of which demand substantial local expertise and time.
Biopharmaceutical companies with limited or no presence in France seek tailored, all-in-one solutions to expedite the setup of an EAP, streamline regulatory approvals, and optimize supply chain logistics, ensuring a swift and efficient launch in the French market.
Early Access Program
Product Fast-Track to France.
We offer biopharmaceutical companies a comprehensive and efficient solution for launching Early Access Programs (EAP) in France.
A ready-to-implement local operational structure is provided, along with expert regulatory guidance and operational integration services.
This approach helps navigate complex regulatory, logistical, and cultural challenges, ensuring a smoother implementation of the EAP and a successful market entry.
In summary, we offer :
- End-to-end support for launching an EAP in France, with expert advice & Exploitant services.
- Provision of a team to manage EAP operations as long as needed.